Ad
related to: pfizer biontech vaccine 2021 availability schedule- For Vaccination Providers
Find Spikevax Information
For Vaccination Providers
- Why Spikevax?
Learn About Spikevax At The
Site for Healthcare Professionals.
- Storage & Handling
Discover Guidelines For Storing
Vaccine Vials.
- Prescribing Information
View The Prescribing Information
For Spikevax.
- Safety & Efficacy
Visit To Learn More About
The Safety & Efficacy of Spikevax.
- Important Safety Info
Visit The Official HCP Site To Find
Important Safety Information.
- For Vaccination Providers
Search results
Results From The WOW.Com Content Network
The Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty, [2] [33] is an mRNA-based COVID-19 vaccine developed by the German biotechnology company BioNTech. For its development, BioNTech collaborated with the American company Pfizer to carry out clinical trials, logistics, and manufacturing.
A CDC advisory panel voted Thursday to recommend COVID-19 boosters of the Pfizer/BioNTech vaccine for a broad population of U.S. residents. The CDC released guidance that overruled the panel.
The COVID-19 vaccination campaign in the United States is an ongoing mass immunization campaign for the COVID-19 pandemic in the United States.The Food and Drug Administration (FDA) first granted emergency use authorization to the Pfizer–BioNTech vaccine on December 10, 2020, [7] and mass vaccinations began four days later.
National regulatory authorities have granted full or emergency use authorizations for 40 COVID-19 vaccines.. Ten vaccines have been approved for emergency or full use by at least one stringent regulatory authority recognized by the World Health Organization (WHO): Pfizer–BioNTech, Oxford–AstraZeneca, Sinopharm BIBP, Moderna, Janssen, CoronaVac, Covaxin, Novavax, Convidecia, and Sanofi ...
The latest vaccines from pharmaceutical companies Moderna and Pfizer/BioNTech target more recent variants of the virus. CDC signs off on latest COVID shot, clearing way for updated vaccines Skip ...
But he said that while Pfizer-BioNTech has submitted the necessary data on booster shots to the Food and Drug Administration (FDA), Moderna has yet to complete the process.
On 16 December 2021, the US Centers for Disease Control and Prevention (CDC) recommended the Moderna and Pfizer-BioNTech vaccines should be preferred over the Janssen vaccine, following growing concerns about rare blood clots. [49] [50] Janssen should still be offered to people who specifically request it. [51]
Pfizer and Moderna said their updated vaccines, which target the XBB.1.5 subvariant of the virus, were expected to be available for most people in the United States in the coming days.